All along we've heard about about expected high demand but today the news is different and refers to actual demand. This says we know the number we need to manufacture:
Avacta is also continuing its discussions with other manufacturers in the UK and overseas in order to access additional capacity to meet demand.
The partnership between Avacta and Mologic also provides a framework agreement for the future development of a pipeline of tests in a range of disease areas.
What I'm trying to say is the sp could be volatile tomorrow but that doesn't mean Avacta won't produce a good lft. Doggy100 post unintentionally suggests if the sp doesn't hold steady tomorrow then Avavt doesn't have a good test
I don't expect any RNS and that way there's not disappointment. Odx have confirmed today that there won't be any RNS until agreements have been signed. Relax.
RE: Avacta supply affimer reagents only not manufacture7 Feb 2021 10:50
Good post Cityone. If anyone thinks Avacta have come this far to have added a nasal test to a saliva test and to then not make a penny in profit, best to sell and jump to Odx.